Neurocrine Biosciences (NBIX) Invested Capital (2010 - 2024)
Neurocrine Biosciences (NBIX) posted quarterly Invested Capital of $122.8 million for Q1 2024, down 27.81% on a QoQ basis from $170.1 million in Q4 2023.
Neurocrine Biosciences (NBIX) Invested Capital (2010 - 2024) Analysis & Trends
Neurocrine Biosciences has reported Invested Capital for 14 years, with the latest figure at $122.8 million in Q1 2024.
- Invested Capital for Q1 2024 came in at $122.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $122.8 million (down 75.91% YoY), and the FY2023 annual result was $170.1 million, changed 0.41% from the prior year.
- Invested Capital eased to $122.8 million in Q1 2024, from $170.1 million in the prior quarter.
- Over five years, Invested Capital peaked at $425.0 million in Q3 2020 and troughed at $122.8 million in Q1 2024.
- A 4-year average of $227.0 million and a median of $169.8 million in 2023 frame the typical range for Invested Capital.
- The largest YoY upside for Invested Capital was 0.41% in 2023 against a maximum downside of 0.41% in 2023.
- A 4-year view of Invested Capital shows it stood at $425.0 million in 2020, then tumbled by 60.14% to $169.4 million in 2022, then rose by 0.41% to $170.1 million in 2023, then declined by 27.81% to $122.8 million in 2024.
- Per Business Quant data, the three most recent Invested Capital figures were $122.8 million in Q1 2024, $170.1 million in Q4 2023, and $169.9 million in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 630.00 Mn |
| 10 | Alkermes | 8.09 Bn | 7.43 Bn | 397.90 Mn | 26.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 122.80 Mn |
| Dec 31, 2023 | 170.10 Mn |
| Sep 30, 2023 | 169.90 Mn |
| Jun 30, 2023 | 169.70 Mn |
| Dec 31, 2022 | 169.40 Mn |
| Sep 30, 2022 | 169.20 Mn |
| Sep 30, 2020 | 425.00 Mn |
| Jun 30, 2020 | 419.50 Mn |
| Dec 31, 2019 | 408.80 Mn |
| Sep 30, 2018 | 383.65 Mn |
| Dec 31, 2017 | 62,000.00 |
| Sep 30, 2017 | 121,000.00 |
| Jun 30, 2017 | 181,000.00 |
| Mar 31, 2017 | 787,000.00 |
| Dec 31, 2016 | 853,000.00 |
| Sep 30, 2016 | 914,000.00 |
| Jun 30, 2016 | 972,000.00 |
| Mar 31, 2016 | 1.04 Mn |
| Dec 31, 2015 | 1.98 Mn |
| Sep 30, 2015 | 2.15 Mn |